105 related articles for article (PubMed ID: 26305168)
1. Cost-Effectiveness Analysis of the Diagnosis and Treatment of Primary Aldosteronism in Japan.
Sato M; Morimoto R; Seiji K; Iwakura Y; Ono Y; Kudo M; Satoh F; Ito S; Ishibashi T; Takase K
Horm Metab Res; 2015 Oct; 47(11):826-32. PubMed ID: 26305168
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients.
Lubitz CC; Economopoulos KP; Sy S; Johanson C; Kunzel HE; Reincke M; Gazelle GS; Weinstein MC; Gaziano TA
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):621-30. PubMed ID: 26555126
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of screening for primary aldosteronism in hypertensive patients in Australia: a Markov modelling analysis.
Woode ME; Wong K; Reid CM; Stowasser M; Russell G; Gwini S; Young MJ; Fuller PJ; Yang J; Chen G
J Hypertens; 2023 Oct; 41(10):1615-1625. PubMed ID: 37466447
[TBL] [Abstract][Full Text] [Related]
4. Detecting and treating primary aldosteronism: primary aldosteronism.
Mantero F; Mattarello MJ; Albiger NM
Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):171-4. PubMed ID: 17427105
[TBL] [Abstract][Full Text] [Related]
5. Primary aldosteronism: A common and curable form of hypertension.
Young WF
Cardiol Rev; 1999; 7(4):207-14. PubMed ID: 10423672
[TBL] [Abstract][Full Text] [Related]
6. The aldosterone/renin ratio as a screening test for primary aldosteronism.
Rayner BL; Opie LH; Davidson JS
S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
[TBL] [Abstract][Full Text] [Related]
7. Screening for primary aldosteronism in the hypertensive obstructive sleep apnea population is cost-saving.
Chomsky-Higgins Menut K; Pearlstein SS; Conroy PC; Roman SA; Shen WT; Gosnell J; Sosa JA; Duh QY; Suh I
Surgery; 2022 Jan; 171(1):96-103. PubMed ID: 34238603
[TBL] [Abstract][Full Text] [Related]
8. [Screening tests and diagnostic examinations of hypertensives for primary aldosteronism].
Omura M; Nishikawa T
Rinsho Byori; 2006 Nov; 54(11):1157-63. PubMed ID: 17240838
[TBL] [Abstract][Full Text] [Related]
9. Primary aldosteronism: emerging trends.
Galati SJ; Hopkins SM; Cheesman KC; Zhuk RA; Levine AC
Trends Endocrinol Metab; 2013 Sep; 24(9):421-30. PubMed ID: 23796656
[TBL] [Abstract][Full Text] [Related]
10. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
[TBL] [Abstract][Full Text] [Related]
11. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.
Naruse M; Katabami T; Shibata H; Sone M; Takahashi K; Tanabe A; Izawa S; Ichijo T; Otsuki M; Omura M; Ogawa Y; Oki Y; Kurihara I; Kobayashi H; Sakamoto R; Satoh F; Takeda Y; Tanaka T; Tamura K; Tsuiki M; Hashimoto S; Hasegawa T; Yoshimoto T; Yoneda T; Yamamoto K; Rakugi H; Wada N; Saiki A; Ohno Y; Haze T
Endocr J; 2022 Apr; 69(4):327-359. PubMed ID: 35418526
[TBL] [Abstract][Full Text] [Related]
12. Primary aldosteronism: renaissance of a syndrome.
Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of primary aldosteronism: an updated review.
Chao CT; Wu VC; Kuo CC; Lin YH; Chang CC; Chueh SJ; Wu KD; Pimenta E; Stowasser M
Ann Med; 2013 Jun; 45(4):375-83. PubMed ID: 23701121
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of screening for primary aldosteronism in China.
Li N; Huang J; Zheng B; Cai H; Liu M; Liu L
Clin Endocrinol (Oxf); 2021 Sep; 95(3):414-422. PubMed ID: 33837588
[TBL] [Abstract][Full Text] [Related]
15. Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.
Young WF
Endocrinology; 2003 Jun; 144(6):2208-13. PubMed ID: 12746276
[TBL] [Abstract][Full Text] [Related]
16. [Primary aldosteronism].
Amar L
Rev Prat; 2015 Jun; 65(6):817-21. PubMed ID: 26298907
[TBL] [Abstract][Full Text] [Related]
17. [Recent progress of diagnosis and treatment of primary aldosteronism].
Omura M; Nishikawa T
Nihon Rinsho; 2011 Nov; 69(11):2071-6. PubMed ID: 22111332
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistant Hypertension.
Velasco A; Chung O; Raza F; Pandey A; Brinker S; Arbique D; Price A; Lotan Y; Das SR; Vongpatanasin W
J Clin Hypertens (Greenwich); 2015 Sep; 17(9):713-9. PubMed ID: 25917401
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
[TBL] [Abstract][Full Text] [Related]
20. The diagnosis of primary aldosteronism and separation of two major subtypes.
Weinberger MH; Fineberg NS
Arch Intern Med; 1993 Sep; 153(18):2125-9. PubMed ID: 8379804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
